Oregon Health and Science University

This is your central portal for breaking news, the latest research and important updates from $name. Bookmark this page and check back often for updates.

In the Journals

Ruxolitinib shows efficacy for certain patients with chronic neutrophilic leukemia, atypical CML

January 24, 2020
Ruxolitinib induced responses in about one-third of a cohort of patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia…
In the Journals

Partial breast reirradiation ‘viable alternative to mastectomy’ for certain women with breast cancer recurrence

January 10, 2020
Partial breast reirradiation without mastectomy appeared as effective as mastectomy for treatment of breast cancer recurrence in the ipsilateral…

ASH presents Scholar Awards to fellows, junior faculty

December 22, 2019
ASH announced the recipients of its 2019 Scholar Awards. The awards — presented to hematologists in the United States and Canada who conduct…
Cover Story

Financial disclosure in oncology leaves ‘room for standardization’

HemOnc Today, November 25, 2019
Reporting of financial ties to industry has become an increasingly contentious, ethically murky area in both oncologic research and clinical…
In the Journals

Invasive prostate cancer incidence rising among young men; cause elusive

November 18, 2019
Incidence of prostate cancer among adolescents and young adults has increased in the United States and many other countries during the past 3…
Commentary

Lymphatic vessels active, anatomical determinants of effective antitumor immunity

November 1, 2019
By Amanda W. Lund, PhD The prevailing model of lymphatic vessel involvement in cancer is that tumor cells use lymphatic vessels as passive escape…
Feature

NCCN’s off-label cancer treatment recommendations ‘constitute a problem’

October 29, 2019
Many novel, costly and toxic cancer therapies continue to be broadly recommended for off-label use by the National Comprehensive Cancer Network based…
In the Journals

Palliative care linked to survival benefit in advanced lung cancer

September 19, 2019
Palliative care appeared associated with survival benefits among patients with advanced lung cancer, according to results of a retrospective study…

New Jersey ‘Aid in Dying’ law for terminally ill takes effect

August 1, 2019
New Jersey has become the eighth state to allow terminally ill patients to request a prescription from a physician for medication to end their…
Cover Story

Aggressive end-of-life care: A disservice to patients

HemOnc Today, July 25, 2019
The availability of more effective and less toxic anticancer agents has made it increasingly difficult for clinicians to discern when to discontinue…
In the Journals

Pembrolizumab after radiotherapy appears safe, induces encouraging responses in lung cancer subset

July 15, 2019
Combining radiotherapy and pembrolizumab appeared safe and induced promising responses among patients with advanced non-small cell lung cancer…
In the JournalsPerspective

Multi-disciplinary workflow increases naloxone access in rural America

July 3, 2019
Pharmacists, front office staff and physicians worked together to boost the number of naloxone prescriptions at a clinic in rural Oregon, according…
Meeting NewsPerspective

BLU-667 exhibits durable activity in RET-altered thyroid cancer

June 3, 2019
CHICAGO — BLU-667 demonstrated durable and potent antitumor activity among patients with RET-altered advanced medullary thyroid cancer or…
In the Journals

Low response rate for checkpoint inhibitors underscores ‘unrealistic expectations’ about their effectiveness

May 30, 2019
An increase in the number of immune checkpoint inhibitors approved by the FDA, along with more indications, means that 43% of patients with cancer in…
Meeting News

CAR T-cell therapy total cost can exceed $1.5 million per treatment

May 29, 2019
PHILADELPHIA — When factoring in all the costs associated with chimeric antigen receptor T-cell therapy, hospitals may charge as much as $1.5…
In the JournalsPerspective

Previous hematologic malignancies increase risk for head and neck cancers

May 23, 2019
Individuals previously diagnosed with a hematologic malignancy appeared at higher risk for developing head and neck cancers, according to results of…
Meeting News

Genetic testing can detect melanoma earlier, but tailored approach is required

March 21, 2019
Genetic testing can help increase early detection of melanoma among patients and their family members, according to a presenter at HemOnc Today New…

Cancer researchers to share $1 million Sjöberg Prize

February 25, 2019
The Royal Swedish Academy of Sciences presented Dennis J. Slamon, MD, and Brian J. Druker, MD, with the 2019 Sjöberg Prize. The $1 million prize…
Cover Story

Early collaboration with psycho-oncologists can make ‘meaningful difference’ in reducing suicide risk

HemOnc Today, January 25, 2019
Despite treatment advances and corresponding improvements in survival, suicide rates among those with cancer are alarmingly high — two times…
Cover Story

#MeToo movement in medicine: ‘Community of allies’ required to end culture of sexual harassment

HemOnc Today, December 10, 2018
The statistics are staggering. Up to 50% of female medical students report experiencing sexual harassment from faculty or staff, according to a…